Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;39(2):104-110.
doi: 10.1097/BPO.0000000000000900.

Osteonecrosis of the Shoulders in Pediatric Patients Treated for Leukemia or Lymphoma: Single-Institutional Experience

Affiliations

Osteonecrosis of the Shoulders in Pediatric Patients Treated for Leukemia or Lymphoma: Single-Institutional Experience

Sue C Kaste et al. J Pediatr Orthop. 2019 Feb.

Abstract

Background: Osteonecrosis of the hips and knees is an often debilitating adverse event in children treated with glucocorticoids for leukemia and lymphoma but the impact of shoulder involvement has been understudied. Thus, we investigated the severity and functional impairment of shoulder osteonecrosis in a well-characterized population of pediatric patients treated for acute lymphoblastic leukemia or lymphoma.

Methods: We retrospectively reviewed orthopaedic clinic and physical therapy evaluations to determine range of motion (ROM), pain, and impact of magnetic resonance-defined osteonecrosis (ON) on activities of daily living. Adverse events were classified according to the National Cancer Institute's Common Terminology Criteria for Adverse Events version 4.03.

Results: We identified 35 patients (22 female), median age at cancer diagnosis 14.2 (range, 4.3 to 19) years; median age at ON diagnosis 16.7 (range, 5.5 to 28) years. Median time to last follow-up from diagnosis of primary malignancy was 6.4 (range, 0 to 12.7) years and from diagnosis of ON was 4.0 (range, 0 to 8.9) years. Twenty-two patients had magnetic resonance evidence of ON; 43 shoulders involved at least 30% of the articular surface of the capital humeral epiphyses.Common Terminology Criteria for Adverse Events mean scores for initial assessments of 55 shoulders (29 patients) showed moderate negative impact of ON on activity of daily living (1.94), decreased ROM limiting athletic activity (0.98), and mild to moderate levels of pain (1.38). Analysis of this group's most recent assessment showed improvement in pain and ON over time, with an average pain grade of 0.58 indicating no pain to mild pain, and 1.37 for ON grade, indicating asymptomatic to mildly symptomatic impact on activities of daily living. We also found minimal worsening average ROM grades (1.11).

Conclusions: Shoulder ON is an underappreciated adverse late effect of therapy in children treated for leukemia/lymphoma which can limit quality of life and functionality. In most cases, pain and disability can be improved with treatment.

Level of evidence: Level IV-case series.

PubMed Disclaimer

Figures

Figure 1
Figure 1
18 year-old girl treated for acute lymphoblastic leukemia (ALL). Asymptomatic osteonecrosis of her hips and knees was identified 6 months into therapy by routine screening MR; involvement of her right elbow was diagnosed 8 years after diagnosis of leukemia. A. (right) and B. (left) Initial shoulder radiographs obtained 23 months after diagnosis of ALL show changes bilaterally of ON, worse on left (B) where a large subchondral crescent is apparent (arrows). Central sclerosis is seen in the right (A) humeral head (arrow). C. and D. Coronal non-contrast T1 and STIR (short tau inversion recovery) MR obtained 2 months later shoulder extensive bilateral changes of ON associated with joint effusions. Her CTCAE functional code (See Table 1) was 3-2-3. She underwent bilateral core decompressions 2 months following the imaging. One month post-operatively, her CTCAE functional code was 2-2-1 bilaterally. E. (right) and F. (left) Forty-one months after the core decompression, the patient’s functional score had deteriorated to 3-2-3. She underwent right-sided hemiarthroplasty 2 months later. Five months after the hemiarthroplasty, her functional scores were 1-1-0, bilaterally.
Figure 1
Figure 1
18 year-old girl treated for acute lymphoblastic leukemia (ALL). Asymptomatic osteonecrosis of her hips and knees was identified 6 months into therapy by routine screening MR; involvement of her right elbow was diagnosed 8 years after diagnosis of leukemia. A. (right) and B. (left) Initial shoulder radiographs obtained 23 months after diagnosis of ALL show changes bilaterally of ON, worse on left (B) where a large subchondral crescent is apparent (arrows). Central sclerosis is seen in the right (A) humeral head (arrow). C. and D. Coronal non-contrast T1 and STIR (short tau inversion recovery) MR obtained 2 months later shoulder extensive bilateral changes of ON associated with joint effusions. Her CTCAE functional code (See Table 1) was 3-2-3. She underwent bilateral core decompressions 2 months following the imaging. One month post-operatively, her CTCAE functional code was 2-2-1 bilaterally. E. (right) and F. (left) Forty-one months after the core decompression, the patient’s functional score had deteriorated to 3-2-3. She underwent right-sided hemiarthroplasty 2 months later. Five months after the hemiarthroplasty, her functional scores were 1-1-0, bilaterally.
Figure 1
Figure 1
18 year-old girl treated for acute lymphoblastic leukemia (ALL). Asymptomatic osteonecrosis of her hips and knees was identified 6 months into therapy by routine screening MR; involvement of her right elbow was diagnosed 8 years after diagnosis of leukemia. A. (right) and B. (left) Initial shoulder radiographs obtained 23 months after diagnosis of ALL show changes bilaterally of ON, worse on left (B) where a large subchondral crescent is apparent (arrows). Central sclerosis is seen in the right (A) humeral head (arrow). C. and D. Coronal non-contrast T1 and STIR (short tau inversion recovery) MR obtained 2 months later shoulder extensive bilateral changes of ON associated with joint effusions. Her CTCAE functional code (See Table 1) was 3-2-3. She underwent bilateral core decompressions 2 months following the imaging. One month post-operatively, her CTCAE functional code was 2-2-1 bilaterally. E. (right) and F. (left) Forty-one months after the core decompression, the patient’s functional score had deteriorated to 3-2-3. She underwent right-sided hemiarthroplasty 2 months later. Five months after the hemiarthroplasty, her functional scores were 1-1-0, bilaterally.
Figure 1
Figure 1
18 year-old girl treated for acute lymphoblastic leukemia (ALL). Asymptomatic osteonecrosis of her hips and knees was identified 6 months into therapy by routine screening MR; involvement of her right elbow was diagnosed 8 years after diagnosis of leukemia. A. (right) and B. (left) Initial shoulder radiographs obtained 23 months after diagnosis of ALL show changes bilaterally of ON, worse on left (B) where a large subchondral crescent is apparent (arrows). Central sclerosis is seen in the right (A) humeral head (arrow). C. and D. Coronal non-contrast T1 and STIR (short tau inversion recovery) MR obtained 2 months later shoulder extensive bilateral changes of ON associated with joint effusions. Her CTCAE functional code (See Table 1) was 3-2-3. She underwent bilateral core decompressions 2 months following the imaging. One month post-operatively, her CTCAE functional code was 2-2-1 bilaterally. E. (right) and F. (left) Forty-one months after the core decompression, the patient’s functional score had deteriorated to 3-2-3. She underwent right-sided hemiarthroplasty 2 months later. Five months after the hemiarthroplasty, her functional scores were 1-1-0, bilaterally.
Figure 1
Figure 1
18 year-old girl treated for acute lymphoblastic leukemia (ALL). Asymptomatic osteonecrosis of her hips and knees was identified 6 months into therapy by routine screening MR; involvement of her right elbow was diagnosed 8 years after diagnosis of leukemia. A. (right) and B. (left) Initial shoulder radiographs obtained 23 months after diagnosis of ALL show changes bilaterally of ON, worse on left (B) where a large subchondral crescent is apparent (arrows). Central sclerosis is seen in the right (A) humeral head (arrow). C. and D. Coronal non-contrast T1 and STIR (short tau inversion recovery) MR obtained 2 months later shoulder extensive bilateral changes of ON associated with joint effusions. Her CTCAE functional code (See Table 1) was 3-2-3. She underwent bilateral core decompressions 2 months following the imaging. One month post-operatively, her CTCAE functional code was 2-2-1 bilaterally. E. (right) and F. (left) Forty-one months after the core decompression, the patient’s functional score had deteriorated to 3-2-3. She underwent right-sided hemiarthroplasty 2 months later. Five months after the hemiarthroplasty, her functional scores were 1-1-0, bilaterally.
Figure 1
Figure 1
18 year-old girl treated for acute lymphoblastic leukemia (ALL). Asymptomatic osteonecrosis of her hips and knees was identified 6 months into therapy by routine screening MR; involvement of her right elbow was diagnosed 8 years after diagnosis of leukemia. A. (right) and B. (left) Initial shoulder radiographs obtained 23 months after diagnosis of ALL show changes bilaterally of ON, worse on left (B) where a large subchondral crescent is apparent (arrows). Central sclerosis is seen in the right (A) humeral head (arrow). C. and D. Coronal non-contrast T1 and STIR (short tau inversion recovery) MR obtained 2 months later shoulder extensive bilateral changes of ON associated with joint effusions. Her CTCAE functional code (See Table 1) was 3-2-3. She underwent bilateral core decompressions 2 months following the imaging. One month post-operatively, her CTCAE functional code was 2-2-1 bilaterally. E. (right) and F. (left) Forty-one months after the core decompression, the patient’s functional score had deteriorated to 3-2-3. She underwent right-sided hemiarthroplasty 2 months later. Five months after the hemiarthroplasty, her functional scores were 1-1-0, bilaterally.

References

    1. te Winkel ML, Pieters R, Hop WC, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2011 Nov 1;29(31):4143–50. - PubMed
    1. Marchese VG, Connolly BH, Able C, et al. Relationships among severity of osteonecrosis, pain, range of motion, and functional mobility in children, adolescents, and young adults with acute lymphoblastic leukemia. Physical therapy. 2008 Mar;88(3):341–50. - PubMed
    1. Kaste SC, Pei D, Cheng C, et al. Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2015 Feb 20;33(6):610–5. - PMC - PubMed
    1. Karimova EJ, Rai SN, Howard SC, et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2007 Apr 20;25(12):1525–31. - PubMed
    1. Hernigou P, Flouzat-Lachaniette CH, Roussignol X, Poignard A. The natural progression of shoulder osteonecrosis related to corticosteroid treatment. Clinical orthopaedics and related research. 2010 Jul;468(7):1809–16. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources